Plain language summary: measuring patient satisfaction with hair regrowth results from ritlecitinib treatment

This Plain Language Summary of Publication article (PLSP) from Immunotherapy describes a study evaluating patient satisfaction with hair regrowth in people with alopecia areata (AA) who took ritlecitinib, an approved medication that blocks immune system components causing hair loss. As part of the ALLEGRO phase 2b/3 trial, participants completed the “Patient Satisfaction with Hair Growth” questionnaire, with one group taking ritlecitinib for 12 months and another taking placebo for 6 months before switching to the medication for the remaining 6 months.

Visit the site using this link to read the article.

This PLSP is based on an article called ‘Patient-Reported Satisfaction with Hair Regrowth in a Study of Ritlecitinib in Alopecia Areata: Results from ALLEGRO-2b/3’ and was published in Dermatology.

Visit Karger using the link to read the original article.

• alopecia areata
• hair regrowth
• patient-reported outcomes
• plain language summary
• ritlecitinib
• satisfaction